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Sibling Recurrence Risk Ratio as a Measure of
Genetic Effect: Caveat Emptor!
To the Editor:
The recent paper by Altmu¨ller et al. (2001) is a laudable
attempt to characterize successful and (mostly) unsuc-
cessful genomewide scans of complex diseases. I wish
to comment on one of the major findings in their
study—that is, that the magnitude of the sibling recur-
rence risk ratio, lS, is not a predictor for the success or
failure of genomewide scans (Altmu¨ller et al. 2001, p.
943).
As perhaps the most widely used measure for familial
aggregation of complex diseases, lS is often used as a
measure of genetic effect and has thus been used for
genetic modeling of complex diseases and for exclusion
mapping in genomewide scans (for excluding chromo-
somal regions that may harbor genes that confer a sibling
recurrence risk ratio of at least, say, 1.5; see, e.g., Cailhier
et al. 2001 and Duffy et al. 2001). Although lS is indeed
an excellent measure for familial aggregation of complex
diseases, it is quite a quantum leap to use it as a measure
of genetic effect, since, for almost all complex diseases,
both environmental and genetic components—all of
which are yet to be identified, in many cases—contribute
to the disease susceptibility.
It has been shown that lS is sensitive to ascertainment
bias and/or overreporting (Guo 1998). Even if the dis-
ease of interest has nothing to do with any genetic com-
ponent, ascertainment bias alone can artificially inflate
lS. In addition, in the complete absence of any genetic
component, multiple interacting environmental factors
shared by siblings would also yield a moderate or even
high value of lS (Guo 2000a). In cases in which, in
addition to environmental components, a genetic com-
ponent does indeed contribute to familial aggregation,
lS is a hodgepodge of genetic and environmental con-
tributions, and, without the identification of genetic fac-
tors, environmental factors, and their interactions, it is
difficult—if not impossible—to make a balance sheet as
to how much effect is due to genes or to environmental
factors (Risch et al. 1993; Guo 2000b). This is due to
the fact that, even in ideal situations (i.e., time-constancy
of genetic effect, random mating, no gene-environment
correlation, etc.), lS can be decomposed as l p 1S
, where G denotes the contribution fromG EG# E
the genetic component, E denotes the contribution from
the environmental component, and denotes theG# E
contribution from gene-environment interactions (Guo
2000b).
It can be seen from the above formula that, in order
to gauge the genetic contribution to lS, one has to know
the effects of at least two of these factors—G, E, or
—since the overall magnitude of lS can be mea-G# E
sured fairly accurately, if it is done with care. It should
be noted that, in measuring E and , it is necessaryG# E
to measure the correlation coefficients of environmental
effects and of the interaction between environmental and
genetic effects, in addition to the identification of the
gene or genes and the environmental factor or factors
(Guo 2000b). These measurements have, unfortunately,
hardly ever been performed so far in published genetic
epidemiological studies. It also can be seen that, since
genetic and environmental factors are entangled to-
gether, exclusion mapping can be a meaningless, make-
believe exercise for multifactorial diseases.
With this in mind, it is perhaps not surprising to see
in the article by Altmu¨ller et al. (2001) that, inconsistent
with the conventional view, the magnitude of lS does
not predict the outcome of a genomewide scan. It can
be further inferred that, in the case of exclusion mapping
of complex diseases known to be multifactorial, it is
futile—as well as, perhaps, illusional—to exclude chro-
mosomal regions that may harbor genes conferring lS
greater than a certain value. Given the theoretical anal-
yses of lS and the empirical findings of Altmu¨ller et al.
(2001), we should exercise extreme caution when it
comes to the use of lS as a measure of the genetic effect
for complex diseases.
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